(
EMAILWIRE.COM, November 29, 2017 ) The
North America mycoplasma testing market was worth USD 148.8 Million in 2016 and is estimated to be growing at a CAGR of 11.5%, to reach USD 256.5 Million by 2021. Mycoplasmas are small bacteria which do not possess a cell wall and they are one of the most prevailing sources of contamination of cell lines. Mycoplasma contamination is a major hurdle for a cell culturist. They are not visible in normal microscopes and their contamination does not alter pH or turbidity significantly.
Mycoplasma infections can be very severe. Mycoplasma contamination occurs if already infected culture is brought into the laboratory or a person with human mycoplasma enters the laboratory. Mycoplasma contamination is a severe problem because they can bring changes in cell culture such as altering cell metabolism, changes in chromosomes of cell culture. Hence, mycoplasma testing is regularly conducted in cell culture research laboratories.
Download Free Sample Report @
http://www.marketdataforecast.com/market-reports/north-america-mycoplasma-testing-market-3663/request-sampleIncrease in investments in R&D in the field of life sciences, government organizations funding researchers in drug discovery and development, increase in the number of pharmaceutical and biotechnology industries are some of the major factors driving the growth of mycoplasma testing market in North America. Stringent government regulations and high costs involved with the mycoplasma testing methods are restraining the market growth.
Buy now @
http://www.marketdataforecast.com/cart/buy-now/north-america-mycoplasma-testing-market-3663/Market Segmentation
Product
Kits & Reagent
Instruments
Services
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
Technique
PCR
ELSA
Direct Assays
Indirect Assays
Microbial culture techniques
Enzymatic Methods
DNA Staining
Y-o-Y Growth Analysis, By Technique
Market Attractiveness Analysis, By Technique
Market Share Analysis, By Technique
Application
Cell Line Testing
Virus Testing
End-Of-Production Cell Testing
Other Applications
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
End User
Pharmaceutical Companies
Contract Research Organizations
Academic Research Institutes
Cell Banks
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Based on region, North America mycoplasma testing market is segmented into USA and Canada. USA dominates the market in this region with many deep rooted pharmaceutical and biotechnology companies established and increase in cell culture research.
Some of the major companies in the mycoplasma testing market include PromoCell GmbH, Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Lonza Group Ltd., Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit,
www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com 
